#1 Clinical Trials Search in Europe

Haemolytic uraemic syndrome – Diagnostics

Go back

Diagnosing haemolytic uraemic syndrome involves a combination of physical examination and laboratory tests that help doctors understand what is happening in your blood and kidneys. Early and accurate diagnosis is crucial because this condition requires immediate medical attention to prevent serious complications, particularly damage to the kidneys and other vital organs.

Introduction: When to Seek Diagnosis

Anyone experiencing bloody diarrhea, especially children under five years old, should seek medical evaluation promptly. Haemolytic uraemic syndrome most commonly affects young children, though adults can also develop the condition and often show more complicated presentations.[1][5]

If you or your child has had diarrhea for more than three days, particularly if it becomes bloody, contact a healthcare provider immediately. This is especially important if the diarrhea is accompanied by decreased urination, unusual tiredness, pale skin, or unexplained bruising. These warning signs may indicate that the condition is progressing beyond a simple intestinal infection.[1][2]

People who have recently eaten food that might be contaminated with certain strains of E. coli bacteria, which are bacteria that can produce harmful toxins, should also be alert to symptoms. This includes undercooked ground beef, unpasteurized dairy products or juices, or produce that hasn’t been properly washed. Additionally, if there’s a known community outbreak of Shiga toxin-producing E. coli, anyone with gastrointestinal symptoms should consider getting tested.[6][8]

⚠️ Important
Haemolytic uraemic syndrome is a medical emergency. If someone with diarrhea shows signs such as peeing much less than usual or not at all, losing color in their cheeks and inside the lower eyelids, unexplained bruising, blood in the urine, extreme tiredness, or decreased alertness, call a doctor or go to the emergency room immediately. Most people with HUS need to be hospitalized because their kidneys may stop working and other serious problems can develop.[6]

Classic Diagnostic Methods

Diagnosing haemolytic uraemic syndrome begins with a thorough physical examination and review of your medical history. Your doctor will ask about recent illnesses, particularly diarrhea, and any foods you may have eaten that could have been contaminated. They will also inquire about family history, as some forms of the disease can be inherited.[9][15]

Blood Tests

Blood tests are essential for diagnosing HUS because they reveal the hallmark features of the condition. These tests check for damaged red blood cells, which is called microangiopathic hemolytic anemia. This term describes a type of anemia where red blood cells break apart as they try to squeeze through small blood vessels that are partially blocked. When doctors examine blood under a microscope, they look for fragmented red blood cells called schistocytes, which appear as broken pieces rather than the normal round shape.[9][16]

Blood tests also measure platelet counts. Platelets are tiny cell fragments that help blood clot, and in HUS, the platelet count drops to abnormally low levels, a condition called thrombocytopenia. This happens because platelets are being used up in forming small blood clots throughout the body’s tiny vessels.[3][12]

Another crucial blood test measures creatinine, which is a waste product that healthy kidneys normally filter out of the blood. When creatinine levels rise higher than normal, it indicates that the kidneys are not working properly. This is one of the key indicators that HUS is affecting kidney function.[9][16]

Additionally, blood tests can reveal whether there is hemolysis occurring. Hemolysis means the breakdown or destruction of red blood cells. Tests may show increased levels of substances released when red blood cells break down, along with a decreased red blood cell count overall. These findings, combined with the other test results, help paint a complete picture of what’s happening in the body.[7][10]

Urine Tests

Urine tests, also called urinalysis, provide important information about kidney function and damage. In HUS, urine tests can detect unusual levels of protein and blood in the urine, both of which suggest that the kidneys’ filtering system has been damaged. Blood in the urine, called hematuria, occurs when damaged blood vessels in the kidneys allow red blood cells to leak into the urine.[9][16]

The presence of protein in urine, known as proteinuria, indicates that the kidney’s filters are not working correctly and are allowing protein molecules that should stay in the blood to pass into the urine. Urine tests may also check for signs of infection, though HUS itself is not caused by a kidney infection.[8][12]

Stool Samples

When HUS is suspected, especially in children with bloody diarrhea, doctors will request stool samples to test for bacteria. These tests specifically look for Shiga toxin-producing E. coli and other bacteria such as Shigella or Salmonella that can trigger HUS. Identifying the specific bacteria helps doctors understand the cause and guides treatment decisions.[9][16]

The stool culture can reveal whether the bacteria producing the toxin are present in the intestines. This is particularly important because most cases of HUS in children are caused by infection with specific strains of E. coli bacteria, particularly the O157:H7 strain. Finding these bacteria in stool samples confirms that the HUS was triggered by this infection.[2][8]

Additional Diagnostic Tests

If the cause of HUS is not immediately clear from the initial tests, or if doctors suspect atypical HUS rather than the infection-related type, additional testing may be necessary. This can include genetic testing to look for inherited mutations that affect how the body’s immune system works. Atypical HUS is a rare form caused by genetic abnormalities that disrupt the complement system, which is part of the body’s defense mechanism.[2][12]

In some cases, doctors may also conduct tests to rule out other similar conditions, such as thrombotic thrombocytopenic purpura (TTP), which shares many features with HUS but requires different treatment. Tests may also check for other possible causes such as certain medications, autoimmune diseases, or pregnancy-related complications.[3][7]

A kidney biopsy, where a small sample of kidney tissue is removed and examined under a microscope, may occasionally be performed. This procedure can show the characteristic damage to small blood vessels in the kidneys and help confirm the diagnosis, especially in atypical or unclear cases. However, biopsies are not routinely needed when the clinical picture and laboratory findings clearly indicate HUS.[10][13]

Diagnostics for Clinical Trial Qualification

When patients with HUS are being considered for enrollment in clinical trials, additional diagnostic criteria and tests may be required beyond those used for routine diagnosis. Clinical trials often have specific eligibility requirements to ensure that participants have a confirmed diagnosis and meet certain health criteria.[11]

For clinical trials involving atypical HUS, genetic testing is frequently required to identify specific mutations in genes that regulate the complement pathway. These genes include complement factor H, complement factor I, membrane cofactor protein, and others. Identifying the exact genetic mutation helps researchers understand how different patients might respond to experimental treatments.[2][13]

Blood tests measuring complement levels and activity may also be standard requirements for trial enrollment. These tests assess how well the complement system is functioning and can help determine whether a patient might benefit from treatments that target this system. Some trials may also require testing for antibodies against complement proteins, which can cause acquired forms of atypical HUS.[10][13]

Clinical trials typically require documentation of kidney function through repeated blood and urine tests. This includes detailed measurements of creatinine clearance and estimated glomerular filtration rate, which are more precise indicators of how well the kidneys are filtering waste. These measurements establish a baseline before treatment begins and help researchers track changes during the trial.[7][11]

For trials testing new medications, participants may need additional screening tests to ensure they don’t have conditions that would make the experimental treatment unsafe. This might include tests for certain infections, pregnancy tests for women of childbearing age, and assessments of other organ function such as the liver and heart. Some trials also require immunization records, particularly for vaccines that prevent meningitis, because certain HUS treatments can increase infection risk.[9][16]

⚠️ Important
Participation in clinical trials is voluntary and should be discussed thoroughly with your healthcare team. While trials offer access to new treatments that might not otherwise be available, they also involve unknown risks. Ensure you understand all the tests required, the potential benefits and risks, and your right to withdraw at any time. Your doctor can help you determine whether a clinical trial is appropriate for your specific situation.

Prognosis and Survival Rate

Prognosis

The outlook for people with haemolytic uraemic syndrome varies depending on several factors, including the type of HUS, how quickly treatment begins, and the severity of kidney damage. For children with typical HUS caused by Shiga toxin-producing E. coli infection, the prognosis is generally favorable when comprehensive supportive care is provided early. Most children recover fully, although some may experience temporary kidney problems requiring dialysis during the acute phase of illness.[1][5]

However, not all cases follow this favorable course. Some children may develop long-term kidney problems, and less than a quarter of those affected may experience chronic kidney dysfunction or even kidney failure that persists after the initial illness resolves. The severity of these lasting effects depends largely on how extensively the kidneys were damaged during the acute episode.[5][20]

Adults and elderly patients tend to show more complicated presentations and may have a less favorable prognosis compared to children. The disease can affect multiple organs beyond the kidneys, including the brain, heart, and liver, which can lead to additional complications. Neurological problems, heart failure, and other organ damage can occur in severe cases.[1][2]

Atypical HUS, which is often caused by genetic mutations or immune system abnormalities, typically requires lifelong treatment and monitoring. Without proper treatment, atypical HUS often leads to chronic kidney disease and may progress to end-stage kidney disease requiring dialysis or kidney transplant. However, newer treatments that specifically target the complement system have significantly improved outcomes for patients with atypical HUS.[2][12]

Survival Rate

The survival rate for haemolytic uraemic syndrome has improved dramatically with modern medical care, particularly in developed countries with access to specialized treatment facilities. Currently, the death rate during acute HUS illness is less than five percent when patients receive appropriate medical care, including supportive treatment, blood transfusions, and dialysis when needed.[1][5]

Most children with typical HUS caused by E. coli infection recover within a few weeks, though the recovery period can vary. Studies show that approximately 1.5 per 100,000 people are affected by HUS each year. Among children with HUS associated with Shiga toxin-producing E. coli, the vast majority survive the acute illness. However, about 8 in 10 children who develop HUS have an underlying E. coli infection that triggered the syndrome.[5][6]

The prognosis becomes more guarded when HUS leads to severe complications or when treatment is delayed. Some patients may suffer permanent health problems or die from complications, particularly if multiple organs are severely affected. The kidneys are especially vulnerable, and approximately half of children with E. coli-associated HUS develop acute kidney injury severe enough to require dialysis temporarily.[15][20]

For patients who progress to end-stage kidney disease and require kidney transplantation, the outcomes are generally good. Kidney transplantation is considered safe and effective for children and adults who have developed permanent kidney failure from HUS. The recurrence rate of HUS in transplanted kidneys is relatively low, ranging from zero to ten percent, though this risk is higher for atypical HUS than for the E. coli-associated form.[11]

Long-term follow-up is essential for all HUS patients because some complications may not appear until months or years after the initial illness. Regular monitoring helps detect problems such as high blood pressure, progressive kidney disease, or protein in the urine early, when interventions can be most effective. With appropriate long-term care and monitoring, many patients with HUS can lead relatively normal lives despite having experienced this serious condition.[11][15]

Ongoing Clinical Trials on Haemolytic uraemic syndrome

References

https://www.mayoclinic.org/diseases-conditions/hemolytic-uremic-syndrome/symptoms-causes/syc-20352399

https://my.clevelandclinic.org/health/diseases/16470-hemolytic-uremic-syndrome

https://www.ncbi.nlm.nih.gov/books/NBK556038/

https://www.kidney.org/kidney-topics/hemolytic-uremic-syndrome-hus

https://en.wikipedia.org/wiki/Hemolytic%E2%80%93uremic_syndrome

https://www.cdc.gov/ecoli/signs-symptoms/hus.html

https://emedicine.medscape.com/article/201181-overview

https://www.vdh.virginia.gov/epidemiology/epidemiology/epidemiology-fact-sheets/hemolytic-uremic-syndrome-hus/

https://www.mayoclinic.org/diseases-conditions/hemolytic-uremic-syndrome/diagnosis-treatment/drc-20352405

https://pmc.ncbi.nlm.nih.gov/articles/PMC4278190/

https://emedicine.medscape.com/article/201181-treatment

https://my.clevelandclinic.org/health/diseases/16470-hemolytic-uremic-syndrome

https://www.ncbi.nlm.nih.gov/books/NBK556038/

https://www.kidney.org/kidney-topics/hemolytic-uremic-syndrome-hus

https://bestpractice.bmj.com/topics/en-us/470

https://www.mayoclinic.org/diseases-conditions/hemolytic-uremic-syndrome/diagnosis-treatment/drc-20352405

https://ahus.org/frequently-asked-questions/

https://ahusnews.com/columns/favorite-tips-make-life-ahus-easier/

https://my.clevelandclinic.org/health/diseases/16470-hemolytic-uremic-syndrome

https://www.niddk.nih.gov/health-information/kidney-disease/children/hemolytic-uremic-syndrome

https://www.kidney.org/kidney-topics/hemolytic-uremic-syndrome-hus

More information about
Haemolytic uraemic syndrome:

FAQ

How long does it take to diagnose haemolytic uraemic syndrome?

Diagnosis can often be made within hours to a day once a patient presents with symptoms and undergoes the necessary blood and urine tests. Doctors look for the characteristic triad of low red blood cell count, low platelet count, and signs of kidney injury. Stool test results to identify the bacteria may take a few days longer, but treatment typically begins immediately based on clinical symptoms and initial blood work rather than waiting for all test results.

Can haemolytic uraemic syndrome be diagnosed before symptoms appear?

In typical cases caused by E. coli infection, HUS cannot be diagnosed before symptoms develop because the condition occurs as a complication of the infection. However, for atypical HUS with a known genetic cause, family members can undergo genetic testing to determine if they carry the mutation, even before any symptoms appear. This doesn’t mean they will definitely develop the disease, as environmental triggers are often needed to activate the condition.

Do all blood tests need to be repeated during HUS treatment?

Yes, blood and urine tests are typically repeated regularly throughout treatment to monitor how well the kidneys are recovering and to track improvements in red blood cell and platelet counts. These repeated tests help doctors adjust treatment as needed and determine when kidney function has returned to normal or whether long-term interventions will be necessary.

Is genetic testing necessary for all HUS patients?

Genetic testing is not necessary for typical HUS cases that clearly result from E. coli infection, especially in children with bloody diarrhea. However, genetic testing is often recommended for atypical HUS, for cases without an obvious infectious trigger, for adults with HUS, for patients with a family history of the condition, or when HUS recurs. The results help guide treatment decisions and determine whether family members should be tested.

What’s the difference between tests for typical and atypical HUS?

For typical HUS, diagnostic tests focus on identifying bacterial infection through stool cultures and assessing the severity of kidney damage and blood cell destruction. For atypical HUS, additional specialized tests are needed, including genetic testing to look for complement system mutations and blood tests to measure complement protein levels and activity. These extra tests help doctors understand the underlying cause and select appropriate treatments that may include complement-blocking medications.

🎯 Key Takeaways

  • • Bloody diarrhea combined with decreased urination, pale skin, or unusual bruising demands immediate medical attention, as these are warning signs of HUS.
  • • A simple blood test can reveal the characteristic triad of HUS: broken red blood cells, low platelets, and elevated creatinine indicating kidney problems.
  • • Stool testing to identify toxin-producing bacteria helps confirm the cause, though treatment usually begins immediately without waiting for these results.
  • • Genetic testing becomes crucial when HUS occurs without obvious infection, appears in adults, runs in families, or when doctors suspect atypical HUS.
  • • Most children with E. coli-triggered HUS recover fully with proper supportive care, though about half temporarily need dialysis during the acute illness.
  • • The survival rate exceeds 95% in developed countries with access to specialized care, representing a dramatic improvement from decades ago.
  • • Clinical trial enrollment requires additional testing beyond standard diagnosis, including detailed genetic analysis and comprehensive complement system evaluation.
  • • Long-term monitoring after recovery is essential because some patients develop chronic kidney problems months or years after the initial illness appears to resolve.

Connected medications: